Year archive

Ab&B Bio-Tech CO., LTD. JS — 2026 filings

All 23 regulatory filings released by Ab&B Bio-Tech CO., LTD. JS (2627) in 2026, sourced directly from the official regulator.

23 Filings

2026 Period

2026 filings (23)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY CHINA CDE FOR MRNA RSV VACCINE Regulatory Filings	2026-05-08	English
FORM OF PROXY FOR THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026 TO BE HELD ON WEDNESDAY, MAY 27, 2026 AND ANY ADJOURNMENT THEREOF Regulatory Filings	2026-05-08	English
(1) ABOLITION OF THE SUPERVISORY COMMITTEE (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION (3) AMENDMENTS TO CERTAIN INTERNAL CORPORATE GOVERNANCE POLICIES (4) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE D Regulatory Filings	2026-05-08	English
NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026 Regulatory Filings	2026-05-07	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026 Regulatory Filings	2026-05-04	English
RESUMPTION GUIDANCE AND CONTINUED SUSPENSION OF TRADING Regulatory Filings	2026-04-29	English
(I) NOMINATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR (II) CHANGE OF BOARD COMMITTEE MEMBERS AND (III) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Board/Management Information	2026-04-24	English
PROPOSED APPOINTMENT OF AUDITOR Regulatory Filings	2026-04-24	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2026-04-19	English
(I) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE (II) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND (III) CHANGE IN MEMBERS OF STRATEGY COMMITTEE OF THE BOARD Board/Management Information	2026-04-19	English
PROPOSED CHANGE OF AUDITOR Regulatory Filings	2026-04-14	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026 Regulatory Filings	2026-04-09	English
EXCHANGE NOTICE - SUSPENSION OF TRADING Regulatory Filings	2026-04-01	English
INSIDE INFORMATION: (1) DELAY IN PUBLICATION OF ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025; (2) POSTPONEMENT OF BOARD MEETING; AND (3) SUSPENSION OF TRADING Report Publication Announcement	2026-04-01	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-19	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO OF STRATEGIC COOPERATION AGREEMENT Regulatory Filings	2026-03-13	English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY U.S. FDA FOR MRNA MPOX VACCINE Regulatory Filings	2026-03-04	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026 Regulatory Filings	2026-03-02	English
PROFIT ALERT - EXPECTED REDUCTION IN LOSS Earnings Release FY 2025	2026-02-26	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026 Share Issue/Capital Change	2026-02-03	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF OUR APPLICATION FOR TRIVALENT SUBUNIT INFLUENZA VACCINE BY THE NMPA Regulatory Filings	2026-01-30	English
(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (2) RESIGNATION OF BOARD SECRETARY AND JOINT COMPANY SECRETARY Board/Management Information	2026-01-12	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025 Share Issue/Capital Change	2026-01-05	English